Abstract
Introduction

36
Sentinel lymph nodes (SLN) are defined as the first lymph node(s) receiving lymphatic 37 drainage from a tumor. Sentinel lymph node mapping and biopsy is performed to stage many types of human cancers [1] [2] [3] [4] and is gaining increasing utility in veterinary medicine. [5] [6] [7] [8] [9] [10] [11] [12] [13] 
39
Sentinel lymph nodes can be presumed based on location of a primary lesion; however, a recent lymph nodes with confirmed metastasis improves survival in both human [3, 4, 16, 17] and 46 veterinary medicine. [14, [18] [19] [20] [21] [22] [23] [24] [25] Based on this information, the importance of identification and 47 sampling of the SLN is clear.
48
Described methods of pre-operative SLN mapping in veterinary medicine include 49 lymphoscintigraphy, [14] contrast-enhanced ultrasonography, [6, 26] lipid-soluble iodinated 50 contrast (LIC) with radiography 12, 14, 15 or computed tomography, [5, 7, 8, 27, 28] expensive and can be difficult to obtain. Additionally, optimal imaging evaluation does not occur 58 until 24 to 48 hours after administration [5, 7] which adds additional cost and time.
59
Previous studies have shown that subcutaneously administered WIC is rapidly absorbed into 60 the local lymphatic channels. [8, 9, 11, 12, 28, 30, 31] in veterinary practices than is computed tomography.
66
The objective of this study was to identify the feasibility of lymphography in healthy dogs 67 using iopamidol (ISOVUE-370, Bracco, Milan, Italy), a WIC, using digital radiography. The 68 hypotheses of this study were that subcutaneously-injected WIC would be identifiable and 69 traceable in the lymphatics and the draining lymph node. Additionally, it was hypothesized that 70 the popliteal lymph node would be the primary lymphatic drainage of the distal pelvic limb.
71
Materials and Methods
72
A prospective, pilot study was designed. The study protocol was approved by the 
103
Results
104
Eight 9-month old, intact male Beagles weighing 13 to 14 kg obtained from a licensed USDA 6 6 105 source were included in this study. All animals were deemed healthy on the basis of physical 106 examination. These dogs were obtained for a use unrelated to this study, however, no other 107 interventions were done prior to this study.
108
Mediolateral radiographic images were obtained of the injected limb pre-injection and at 109 times 0, 3, 5, 10, and 20 minutes post-injection in all dogs. Based on degree of lymph node 110 enhancement in the first three dogs the study protocol was modified to include radiographs up to 111 60 minutes if necessary to achieve lymph node enhancement. Thus, mediolateral images were 112 taken at 30 and 40 minutes in 5 of the 8 dogs and at 50 minutes in 1 dog.
113
One milliliter of WIC was injected into the subcutaneous tissue on the plantar aspect of the 114 pes in 1 dog, 2 milliliters of contrast was injected on the plantar aspect in 6 dogs, and 1 milliliter 115 was injected into the subcutaneous tissues of both the plantar and dorsal aspects, for a total of 2 116 milliliters, of the pes in 1 dog. The volume of WIC was increased after the first dog, as the 117 contrast material was visible within the lymphatics and approaching the popliteal lymph node 118 within the study period, however, nodal enhancement did not occur. The final dog in this study 119 was injected on both the plantar and dorsal aspects of the pes in response to identification of a 120 lymphatic pathway from the dorsal aspect of the pes to the popliteal lymph node. to a more caudal position in its course to the popliteal lymph node (n=7); and lymphatic drainage 130 via a third lymphatic channel which was neither dorsal nor plantar drained to the popliteal lymph 131 node (n=1) (Fig 1) . Six of 8 dogs had both the dorsal and plantar pathways enhance, 1 dog had 132 both the third channel and plantar pathways enhance, and 1 dog had only the dorsal pathway popliteal lymph node occurred in one dog at 20 and 50 minutes, respectively (Fig 3) .
159
Enhancement of separate afferent lymphatics leading to each lymph node from the injection site 160 were identifiable, and there were no visible efferent lymphatics from either lymph node. leads to the contrast enhanced popliteal lymph node, identified by the long, outlined white arrow.
171
The caudal lymphatic channel, depicted by the short, solid white arrows, is contrast enhanced 
Discussion
184
To the authors' knowledge, this is the first study evaluating the effectiveness of radiography 185 for lymphography using subcutaneously-injected WIC. Findings of this study show indirect 186 lymphography with WIC to be feasible for evaluating the lymphatic drainage of the pes. Alternatively, 1 milliliter of contrast material may not be sufficient to enhance the draining 208 lymph node in all cases, irrespective of time after injection. In a study by Grimes et al[32] , 78% 209 (7/9) of dogs injected with 1 ml of contrast had SLNs identified by computed tomographic 210 evaluation in comparison to 100% (9/9) of dogs injected with 2 milliliters of contrast.
211
Confounding factors theorized to be impacting detection of drainage to the SLN in that study 212 included tumor compression of lymphatics, patient positioning, and/or endotracheal tube ties 213 causing collapse or restriction of lymphatic flow. These factors were not a part of this study 214 suggesting that an additional confounder, such as time or volume of contrast material, was the 215 main factor for the negative result here. Considering these findings, the authors recommend 216 using 2 mls of WIC for lymphographic evaluation with radiographs. Based on the results of this study, subcutaneously-injected, water-soluble, iodinated contrast 237 material provides a relatively quick and effective means of tracing the lymphatic channels from 238 the pes to the draining lymph node(s). The results of this study also show that one cannot assume 239 that the distal pelvic limb will have primary lymphatic drainage only to the popliteal lymph node. 
